NCT00189813View on ClinicalTrials.gov

A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

PHASE2CompletedINTERVENTIONAL
Enrollment

691

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

YM060

Trial Locations (45)

Unknown

Plovdiv

Sofia

Varna

České Budějovice

Hradec Králové

Ostrava Hrabuvka

Prague

Tábor

Ústí nad Orlicí

Tallinn

Tartu

Viljandi

Berlin

Bochum

Dietzenbach

Essen

Frankfurt

Friedberg

Hamburg

Haßloch

Königstein

Leipzig

Mainz

Marburg

Potsdam

Waltershausen

Kaunas

Klaipėda

Vilnius

Bialystok

Bydgoszcz

Krakow

Leszno

Lublin

Oława

Warsaw

Moscow

Saint Petersburg

Yaroslavl

Dnipropetrovsk

Kiev

Lviv

Odesa

Simferopol

Sumy

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Europe B.V.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY